NK cell immunotherapy administered at the time of HIV recrudescence is associated with viral control.
Liliana Kopeck Thron, Pongthorn Pumtang-on, Jae‐Woong Chang, Maxwell E. Cantor, Ian Gorrell-Brown, Kelsie L. Becklin, Zoe E. Quinn, Ahmad Faisal Karim, Aaron Rendahl, Mary S. Pampusch, Sofia A. Casares, Vaiva Vezys, Branden S. Moriarity, Pamela J. Skinner
This study evaluates CAR/CXCR5 NK cells in HIV-infected humanized mice, showing improved viral control when administered during viral recrudescence.
bioRxiv · Nov 19, 2025 · PreprintBioengineering